Evotec advancing first-in-class therapies via Almirall collab
Evotec and Almirall are using a novel approach to disrupt cell signaling to discover and develop first-in-class therapeutics targeting dermatology diseases.
Archives for September 17, 2018
‘Revamped’ MannKind secures $105m licensing deal, plans Afrezza expansion
MannKind Corporation, of Afrezza fame, and United Therapeutics have signed an exclusive licensing and collaboration agreement for dry powder pulmonary hypertension products.
New Parexel Innovation Center to help guide sponsor's patient-centricity initiatives
The global biopharmaceutical services provider has launched the Patient Innovation Center to help sponsors implement patient-centric initiatives — an area in which the company is committed to innovate, says executive.
US FDA ups the ante against antimicrobial resistance
The US FDA announced a number of measures it considers as a viable means of combatting AMR, including the idea of hospitals paying a ‘subscription’ to access new medicines.
NORDIC LIFE SCIENCE DAYS
Roche looks beyond clinical trial data to ‘transform oncology’
Deep, rich, and high quality data sets can help inform patients and enrich the industry’s understanding of cancer, says Roche executive.
Looking to the future of a safe supply chain
in-PharmaTechnologist (IPT) speaks to Ettore Cucchetti (EC), CEO of ACGI, about how the biopharma industry is adapting to the threat of counterfeit medicine and how he expects the industry will adopt further measures beyond those stipulated in the EU FMD.